WELCOME to: 'Stu's Views and MS News' an informational archive

· Key-Note: This blog provides information and resources to benefit those affected by Multiple Sclerosis.

· Our live MS educational seminars average 67 people per educational program. SINCE our first program in February 2010, we have hosted more than 130 educational programs.

· Register at our website (MS Views and News) to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in more than (90) Countries. Visit MS Views and News.org

· WATCH OUR Multiple Sclerosis archived MS EDUCATIONAL VIDEOS by Topic. Click: www.youtube.com/msviewsandnews

Be Empowered with Beneficial MS Information

Scroll to view all the resources found on the left side of this blog. Use our 'search by topic' tool, when wanting to find specific information.

===================================================================

Saturday, February 9, 2013

Reprogramming skin cells to benefit brain cells in Multiple Sclerosis


Treating Multiple Sclerosis with Skin

February 8, 2013

Reprogrammed skin cells can be turned into brain cells that may be highly effective in treating myelin disorders like multiple sclerosis and pediatric leukodystrophies, according to researchers at the University of Rochester Medical Center (URMC). The team says that their study is the first successful attempt to employ human induced pluripotent stem cells (hiPSC) to produce a population of cells that are critical to neural signaling in the brain. The scientists used cells crafted from human skin and transplanted them into animal models of myelin disease.
"This study strongly supports the utility of hiPSCs as a feasible and effective source of cells to treat myelin disorders," says URMC neurologist Steven Goldman, M.D., Ph.D., lead author of the study. "In fact, it appears that cells derived from this source are at least as effective as those created using embryonic or tissue-specific stem cells." The team adds that the discovery opens the door to potential new treatments using hiPSC-derived cells for a range of neurological diseases characterized by myelin loss.
Oligodendrocytes are the source of myelin in the brain and spinal cord. Oligodendrocytes themselves are the offspring of oligodendrocyte progenitor cells, or OPCs. Scientists have theorized that if healthy OPCs could be successfully transplanted into the diseased or injured brain, then these cells might be able to produce new oligodendrocytes capable of restoring lost myelin, thereby reversing the damage caused by these diseases. However, one of the key challenges is that OPCs are a mature cell in the central nervous system and appear late in development.

CONTINUE READING
..


If you would like, you can comment to our blog posts
 LIKE this Blog by clicking the LIKE button - top left
 REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org  to register
.

No comments: